These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 27488911)

  • 1. An automated method measures variability in P-glycoprotein and ABCG2 densities across brain regions and brain matter.
    Kannan P; Schain M; Kretzschmar WW; Weidner L; Mitsios N; Gulyás B; Blom H; Gottesman MM; Innis RB; Hall MD; Mulder J
    J Cereb Blood Flow Metab; 2017 Jun; 37(6):2062-2075. PubMed ID: 27488911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abundance of P-Glycoprotein and Other Drug Transporters at the Human Blood-Brain Barrier in Alzheimer's Disease: A Quantitative Targeted Proteomic Study.
    Storelli F; Billington S; Kumar AR; Unadkat JD
    Clin Pharmacol Ther; 2021 Mar; 109(3):667-675. PubMed ID: 32885413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of ABC transporters in the pathogenesis of Alzheimer's disease.
    Abuznait AH; Kaddoumi A
    ACS Chem Neurosci; 2012 Nov; 3(11):820-31. PubMed ID: 23181169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain Distribution of Dual ABCB1/ABCG2 Substrates Is Unaltered in a Beta-Amyloidosis Mouse Model.
    Wanek T; Zoufal V; Brackhan M; Krohn M; Mairinger S; Filip T; Sauberer M; Stanek J; Pekar T; Pahnke J; Langer O
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33153231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of amyloid beta on ATP-binding cassette transporter expression and activity in porcine brain microvascular endothelial cells.
    Shubbar MH; Penny JI
    Biochim Biophys Acta Gen Subj; 2018 Oct; 1862(10):2314-2322. PubMed ID: 30048740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood-Brain Barrier Disruption Increases Amyloid-Related Pathology in TgSwDI Mice.
    Abdallah IM; Al-Shami KM; Yang E; Kaddoumi A
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33513818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ABCG2 is upregulated in Alzheimer's brain with cerebral amyloid angiopathy and may act as a gatekeeper at the blood-brain barrier for Abeta(1-40) peptides.
    Xiong H; Callaghan D; Jones A; Bai J; Rasquinha I; Smith C; Pei K; Walker D; Lue LF; Stanimirovic D; Zhang W
    J Neurosci; 2009 Apr; 29(17):5463-75. PubMed ID: 19403814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ABCG2- and ABCG4-mediated efflux of amyloid-β peptide 1-40 at the mouse blood-brain barrier.
    Do TM; Noel-Hudson MS; Ribes S; Besengez C; Smirnova M; Cisternino S; Buyse M; Calon F; Chimini G; Chacun H; Scherrmann JM; Farinotti R; Bourasset F
    J Alzheimers Dis; 2012; 30(1):155-66. PubMed ID: 22391220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease.
    Ikonomovic MD; Klunk WE; Abrahamson EE; Mathis CA; Price JC; Tsopelas ND; Lopresti BJ; Ziolko S; Bi W; Paljug WR; Debnath ML; Hope CE; Isanski BA; Hamilton RL; DeKosky ST
    Brain; 2008 Jun; 131(Pt 6):1630-45. PubMed ID: 18339640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restoring blood-brain barrier P-glycoprotein reduces brain amyloid-beta in a mouse model of Alzheimer's disease.
    Hartz AM; Miller DS; Bauer B
    Mol Pharmacol; 2010 May; 77(5):715-23. PubMed ID: 20101004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of P-Glycoprotein, a β-Amyloid Transporter at the Blood-Brain Barrier, Is Compromised in Patients with Mild Alzheimer Disease.
    Deo AK; Borson S; Link JM; Domino K; Eary JF; Ke B; Richards TL; Mankoff DA; Minoshima S; O'Sullivan F; Eyal S; Hsiao P; Maravilla K; Unadkat JD
    J Nucl Med; 2014 Jul; 55(7):1106-11. PubMed ID: 24842892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ATP-binding cassette transporters P-glycoprotein and breast cancer related protein are reduced in capillary cerebral amyloid angiopathy.
    Carrano A; Snkhchyan H; Kooij G; van der Pol S; van Horssen J; Veerhuis R; Hoozemans J; Rozemuller A; de Vries HE
    Neurobiol Aging; 2014 Mar; 35(3):565-75. PubMed ID: 24138987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gram-negative bacterial molecules associate with Alzheimer disease pathology.
    Zhan X; Stamova B; Jin LW; DeCarli C; Phinney B; Sharp FR
    Neurology; 2016 Nov; 87(22):2324-2332. PubMed ID: 27784770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New Evidence for P-gp-Mediated Export of Amyloid-β PEPTIDES in Molecular, Blood-Brain Barrier and Neuronal Models.
    Chai AB; Hartz AMS; Gao X; Yang A; Callaghan R; Gelissen IC
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33383667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induced expression of P-gp and BCRP transporters on brain endothelial cells using transferrin functionalized nanostructured lipid carriers: A first step of a potential strategy for the treatment of Alzheimer's disease.
    Arduino I; Iacobazzi RM; Riganti C; Lopedota AA; Perrone MG; Lopalco A; Cutrignelli A; Cantore M; Laquintana V; Franco M; Colabufo NA; Luurtsema G; Contino M; Denora N
    Int J Pharm; 2020 Dec; 591():120011. PubMed ID: 33115695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations of quantitative susceptibility mapping with Alzheimer's disease clinical and imaging markers.
    Cogswell PM; Wiste HJ; Senjem ML; Gunter JL; Weigand SD; Schwarz CG; Arani A; Therneau TM; Lowe VJ; Knopman DS; Botha H; Graff-Radford J; Jones DT; Kantarci K; Vemuri P; Boeve BF; Mielke MM; Petersen RC; Jack CR
    Neuroimage; 2021 Jan; 224():117433. PubMed ID: 33035667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural Products based P-glycoprotein Activators for Improved β-amyloid Clearance in Alzheimer's Disease: An in silico Approach.
    Shinde P; Vidyasagar N; Dhulap S; Dhulap A; Hirwani R
    Cent Nerv Syst Agents Med Chem; 2015; 16(1):50-9. PubMed ID: 26306632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemically-defined pools of amyloid-β in sporadic Alzheimer's disease: correlation with amyloid PET.
    Roberts BR; Lind M; Wagen AZ; Rembach A; Frugier T; Li QX; Ryan TM; McLean CA; Doecke JD; Rowe CC; Villemagne VL; Masters CL
    Brain; 2017 May; 140(5):1486-1498. PubMed ID: 28383676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-definition characterization of cerebral β-amyloid angiopathy in Alzheimer's disease.
    Soontornniyomkij V; Choi C; Pomakian J; Vinters HV
    Hum Pathol; 2010 Nov; 41(11):1601-8. PubMed ID: 20688356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ABC efflux transporters in brain vasculature of Alzheimer's subjects.
    Wijesuriya HC; Bullock JY; Faull RL; Hladky SB; Barrand MA
    Brain Res; 2010 Oct; 1358():228-38. PubMed ID: 20727860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.